发明名称 |
SCHEME FOR ADMINISTERING N-HYDROXY-4-{2-[3-(N,N-DIMETHYLAMINOMETHYL)BENZOFURAN-2-YLCARBONYLAMINO]ETHOXY}BENZAMIDE |
摘要 |
<p>N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}-benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, alone or in association with surgery, chemotherapy or hormone therapy treatment or radiotherapy, for use in the treatment of cancer, characterised in that it is administered for 4 consecutive days, that period being followed by 3 consecutive days without any administration of compound of formula (I), with the proviso that the chemotherapy is not FOLFOX.</p> |
申请公布号 |
SG11201400120U(A) |
申请公布日期 |
2014.09.26 |
申请号 |
SG11201400120U |
申请日期 |
2012.09.07 |
申请人 |
LES LABORATOIRES SERVIER;PHARMACYCLICS INC. |
发明人 |
KLOOS, IOANA;ROBERT, RENATA;JACQUET-BESCOND, ANNE;DEPIL, STÉPHANE;CHENEL, MARYLORE;FOULIARD, SYLVAIN;BALASUBRAMANIAN, SRIRAM |
分类号 |
A61K31/138;A61K31/343;A61K31/704;A61K33/24;A61P35/00 |
主分类号 |
A61K31/138 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|